04.08.14
Irvine, CA-based ChromaDex Corp., a natural products company that provides proprietary ingredients and science-based solutions to the dietary supplement, food and beverage, animal health, cosmetic and pharmaceutical industries, has entered into a joint collaboration agreement with Brazilian Biosciences National Laboratory (LNBio) to evaluate ChromaDex's natural product libraries.
ChromaDex and LNBio are establishing a collaboration to screen natural product libraries against certain molecular targets and phenotypic assays with the intent of identifying high value, possibly patentable natural products for specific therapeutic indications. Under the terms of the agreement, ChromaDex will be responsible for providing the natural product libraries for screening, as well as the natural product chemistry expertise to continue the development of any identified candidates into commercial opportunities. LNBio will screen the natural product libraries provided by ChromaDex, as well as continue performing assays in enzymes, cells and organisms related to the discovery of chemical entities that are the object of this collaboration.
"ChromaDex's expertise in developing natural product libraries, and natural products chemistry, as well as its success in commercializing novel, branded ingredients, makes ChromaDex the ideal partner for this type of high throughput screening collaboration," said Kleber Gomes Franchini, director of LNBio. "If successful, this collaboration could lead to rapid commercialization of novel natural products for food, beverage, cosmetic or pharmaceutical applications."
"The ChromaDex catalog offers thousands of very unique phytochemical compounds primarily isolated from botanicals," said Frank Jaksch, Jr., founder and CEO of ChromaDex. "We are very excited to start this collaboration with LNBio, as this program will allow ChromaDex to extract value from the natural products library we have been developing over the past 15 years."
ChromaDex and LNBio are establishing a collaboration to screen natural product libraries against certain molecular targets and phenotypic assays with the intent of identifying high value, possibly patentable natural products for specific therapeutic indications. Under the terms of the agreement, ChromaDex will be responsible for providing the natural product libraries for screening, as well as the natural product chemistry expertise to continue the development of any identified candidates into commercial opportunities. LNBio will screen the natural product libraries provided by ChromaDex, as well as continue performing assays in enzymes, cells and organisms related to the discovery of chemical entities that are the object of this collaboration.
"ChromaDex's expertise in developing natural product libraries, and natural products chemistry, as well as its success in commercializing novel, branded ingredients, makes ChromaDex the ideal partner for this type of high throughput screening collaboration," said Kleber Gomes Franchini, director of LNBio. "If successful, this collaboration could lead to rapid commercialization of novel natural products for food, beverage, cosmetic or pharmaceutical applications."
"The ChromaDex catalog offers thousands of very unique phytochemical compounds primarily isolated from botanicals," said Frank Jaksch, Jr., founder and CEO of ChromaDex. "We are very excited to start this collaboration with LNBio, as this program will allow ChromaDex to extract value from the natural products library we have been developing over the past 15 years."
